Spectrum Science has continued its expansion in the healthcare industry with the strategic acquisition of clinical trial enrollment company Continuum Clinical. The announcement was made on Thursday morning, and while the terms of the deal were not immediately disclosed, Spectrum Science purchased the firm from independent marketing agency Blue Chip Worldwide.
The acquisition of Continuum Clinical will join Spectrum’s existing clinical trial recruitment strategic pillar, and Neil Weisman will continue as president of the organization. CEO Jonathan Wilson hailed the acquisition as an opportunity for the agency to expand its presence in the patient recruitment space. With backing from private equity firm Knox Lane, Spectrum Science continues to be an active player in the agency M&A arena.
This latest acquisition comes after Spectrum Science’s purchase of healthcare agencies CrowdPharm and Hot Iron Health a few months earlier. The combined company will be led by CrowdPharm MD and partner Mike Myers, who will serve as president and lead day-to-day operations. Continuum Clinical president Weisman expressed excitement over joining a partner that holds a compatible view of the future of patient recruitment.